Observed MAUDE disclosed-group reporting stress
In plain terms
Test whether an observed change in a disclosed subsidiary reporting cohort precedes stock weakness.
How it works
Internal exploratory hypothesis on death/injury report-share changes for exact FDA reporting-manufacturer G1 names linked to a listed issuer by its last SEC subsidiary roster published before the decision. The roster is a dated proxy, not proof of uninterrupted ownership.
Data dependencies
- Daily prices
Adjusted-close OHLCV for every US-listed ticker; primary price feed.
- Maude reporting disclosed group snapshots
A data feed this strategy reads, refreshed on its normal schedule.
Expected edge
See the source research for the original effect size; a modern replication on new data may be weaker.
Example tickers where this is likely to fire
Illustrative only, the signal fires based on the live data, not a fixed list.
Related families
The original device-report strategy remains inactive; its historical publication series is incomplete.
Test whether a published change in a company’s device-report mix predicts stock weakness.
Explore Observed MAUDE disclosed-group reporting stress on alphactor.ai
See which tickers this family is currently firing on, with live signals and rankings.